Business
Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics
Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics.
About this update from Hypha Labs, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics\r\n \r\n \r\n\r\n\r\nHypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics\r\n\r\n\r\n\r\n\r\n\r\nLAS VEGAS, NV, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, today announced the official launch of Phase II in its strategic partnership with Tryptomics, uniting Hypha's patented Mushroom Accelerator™ platform with Tryptomics On-Site™ Science Services & their contract R&D Metabolomics Pipeline to develop Hypha Labs proprietary varieties of bioreactor-optimized species and providing the gold-standard in quality assurance testing at Hypha Labs. The collaboration accelerates R&D cycles and advances the future of at-home, pharmaceutical-grade mushroom wellness.\r\n Phase I introduced a dual-track approach to validation and scalability:\r\n \r\n Tryptomics On-Site™: Hypha Labs has accelerated its in-house analytical testing capabilities by partnering with Tryptomics to implement their in-depth analytical testing methods to optimize the accelerator's production.\r\n Third-Party Verification Role: Tryptomics serves as an independent validation lab, confirming Hypha's internal results through Certificate of Analysis (COA) verification and reproducibility benchmarking.\r\n Bioreactor Deployment & Duplication: Tryptomics has been equipped to deploy and operate duplicate Mushroom Accelerators™ in-house, mirroring Hypha Lab's systems for synchronized experimentation and protocol testing.\r\n Genetics Collaboration: Through discussions and planning, Hypha Labs and Tryptomics is excited to announce the advancement of its mycology program through Tryptomics' next-generation sequencing analyses, TryptoMatics™ and marker assisted breeding, TryptoTyping™.\r\n \r\n The program also targets rapid, reproducible production of bioavailable Micro-Pearls in just eight days, providing faster iteration and scalability. With third-party COAs and internal quality control forthcoming, ...